M. Marinkovich

601 Measurement of skin adherence in recessive dystrophic epidermolysis bullosa patients

591 A phase 1/2 study of genetically-corrected, collagen VII expressing autologous human dermal fibroblasts injected into the skin of patients with recessive dystrophic epidermolysis bullosa (RDEB)

572 Defining chronic wound types in recessive dystrophic epidermolysis bullosa patients for clinical outcome assessment

328 50% wound healing correlates with RDEB patient reported outcomes in pain, itch and skin durability

700 ITK and RLK inhibitor improves skin disease in a psoriatic mouse model

811 Attenuated netrin-1 receptor mediated regulation of tiam1 is required for rac1 mutant melanoma progression

308 Bone marrow/cord blood transplantation (BMCBT) ameliorates symptoms in some, but not all, subtypes of severe generalized junctional epidermolysis bullosa (JEB)

219 Natural history of chronic wounds in patients with recessive dystrophic epidermolysis bullosa

224 Quality of life in recessive dystrophic epidermolysis bullosa: The AltaVoice patient registry, 2012-2015

215 Validity and accuracy of a mobile phone application for the assessment of chronic wounds in recessive dystrophic epidermolysis bullosa